ADJUVANT CHEMOTHERAPY IN THE NODE-NEGATIVE BREAST-CANCER PATIENT

Authors
Citation
Tm. Styblo et Wc. Wood, ADJUVANT CHEMOTHERAPY IN THE NODE-NEGATIVE BREAST-CANCER PATIENT, The Surgical clinics of North America, 76(2), 1996, pp. 327
Citations number
26
Categorie Soggetti
Surgery
ISSN journal
00396109
Volume
76
Issue
2
Year of publication
1996
Database
ISI
SICI code
0039-6109(1996)76:2<327:ACITNB>2.0.ZU;2-X
Abstract
Adjuvant therapy in women with axillary node metastases from breast ca ncer is beneficial, but the role of adjuvant therapy in women with nod e-negative breast cancer is controversial. By definition, all clinical ly apparent disease can be removed surgically in patients with early b reast cancer. Although the majority of patients with early breast canc er are cured with surgical therapy alone, about 30% of node-negative p atients eventually will die of their disease. The identification of th is subgroup of high-risk patients is imperative in order to decrease d isease recurrence.